Mr. Hugo Alves reports
AUXLY ANNOUNCES RESULTS OF ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS
Auxly Cannabis Group Inc. has released the voting results from its annual general and special meeting of shareholders held on June 28, 2021.
A total of 132,758,409 common shares of the company, representing 17.62 per cent of the issued and outstanding common shares of the company, were voted in connection with the meeting by shareholders and proxyholders.
All of the matters put forward before the company's shareholders for consideration and approval, as set out in the company's information circular dated May 20, 2021, were approved by the requisite majority of the votes cast at the meeting. The results are disclosed herein.
Each of the directors listed as a nominee in the circular was elected as a director of the company at the meeting. The detailed results of the vote for the election of directors held at the meeting are provided in an attached table.
At the meeting, Auxly shareholders approved the reappointment of Ernst & Young LLP as the company's auditor for the 2021 fiscal year and authorized the board of directors to fix the auditor's remuneration.
In addition, in accordance with Multilateral Instrument 61-101 -- Protection of Minority Security Holders in Special Transactions, the Imperial Brands amendment resolution (as defined in the circular) was approved by 99.26 per cent of the votes cast at the meeting, excluding the common shares of the company beneficially owned or controlled, directly or indirectly, by Imperial Brands and its affiliates. The company's shareholders also approved the adoption of the amended and restated omnibus plan of the company (as defined in the circular).
A report of voting results on all resolutions voted on at the meeting will be available on SEDAR.
About Auxly Cannabis Group Inc.
Auxly Cannabis Group is a leading Canadian cannabis company dedicated to bringing innovative, effective and high-quality cannabis products to the wellness and adult-use markets. Auxly's experienced team of industry first movers and enterprising visionaries has secured a diversified supply of raw cannabis, strong clinical, scientific and operating capabilities, and leading research and development infrastructure in order to create trusted products and brands in an expanding global market.
© 2021 Canjex Publishing Ltd. All rights reserved.